Role of biomarkers in chemotherapy-induced cardiotoxicity.
about
The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer TherapyCardiac toxicity in cancer survivorsSerum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patientsExpert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.Noninvasive diagnosis of chemotherapy related cardiotoxicityDiagnostic Strategies for Early Recognition of Cancer Therapeutics-Related Cardiac Dysfunction.Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trMorphine enhances doxorubicin-induced cardiotoxicity in the rat.HER2 signaling pathway and trastuzumab cardiotoxicity.Cardiovascular disease after cancer therapy.Breast cancer survivorship issues.Acute cardiotoxicity evaluation of the marine biotoxins OA, DTX-1 and YTXSerial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantationDiastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors.Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclinesThe potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics.Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.Late effects in childhood cancer survivors: a review with a framing effect bias?Role of biomarkers in cardioncology.Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology.Cardiac toxicity of targeted therapies used in the treatment for solid tumours: a review.Using cardiac biomarkers and treating cardiotoxicity in cancer.Cardiac toxicity of anticancer agents.Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.Anthracycline-Induced Cardiomyopathy in Adults.A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.Identifying cancer patients at risk for cardiotoxicity.Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.Cardio-oncology in the older adult.Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment.Putting it into perspective: multimarker panels for cardiovascular disease risk assessment.Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.Cardiac complications of chemotherapy: role of biomarkers.The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice GuidelinesBioinformatics identification of potential candidate blood indicators for doxorubicin-induced heart failureCardio-oncology: A Focus on Cardiotoxicity
P2860
Q26743433-5042C151-4482-4E29-8CBF-AB15A5019F18Q26851957-B2E44FCB-CFEF-4319-B92E-9341F5818247Q27007849-F907F014-5325-41E8-A731-A52EEDEA9312Q30401812-19092576-35A8-4968-B59E-85142F74BC21Q30461444-ED32ECBD-449A-4EC7-9C46-FE4C86F28B4FQ33565936-87FD2A00-C461-4828-BCF4-AAD5D1EAF6ACQ33973013-96CDE801-36CE-43E4-9277-00DA0AEFF452Q34048494-8549ED44-FE28-48FE-AF0C-13F741651574Q34328064-A113BE4D-311B-4384-92BF-1094BA05EAB2Q34604429-4D7A5FB2-4C60-4307-8D0C-33EA5A3D1A7EQ34895561-C5904D81-BCF5-4756-9AB9-966C4151391BQ35564017-AEF21FCC-DA33-40C5-A71F-1552AA3E42A6Q35800366-BCE95FAD-1C38-4B0E-B30D-73B4DB3492D8Q35915714-10260463-6A64-4142-B7E3-FF2FB8F84C50Q36416745-AB4DD4CD-DF45-45A6-AC00-0986EC0387E9Q36630478-F4856C27-5A5F-4069-9EBF-E464B973906BQ36887091-4E2B6704-28AD-425B-9C2F-C2E073A6F229Q37831281-176642DA-D712-41EF-9A45-EC5D7BDD8544Q37926595-2D2A104E-B063-4A67-B86C-0E37791E913EQ37967508-C947CCBD-52C2-4B5D-BDCD-58713684E81AQ38005052-6D21561E-9FF6-48B7-AF96-FDFD103B9D52Q38069202-54C1A6EF-3AE3-4EC6-8E7B-34D23A803EB3Q38091377-82E5E6AE-138D-49CF-BEDB-A87533496132Q38097736-DD17FD02-CA8F-47E7-9973-C60BD2CA4EEAQ38542462-AC041BB6-B0B8-495C-A3C9-2236AD808F89Q38545052-0745CE30-17CB-43BD-BABA-83445EC58EF5Q38551772-D6694C0A-42FE-4DEF-A7F7-C9C050DA923FQ38559474-47075B25-486F-4541-85A6-551E1B5B066BQ38632789-36DD14BD-83FA-4FAE-9D5E-8895339D5EB5Q38717558-C16F73CD-8609-4412-ABCC-5D08554684C5Q38735433-BDC7A58E-67C6-4FB5-858D-7B56E0B53307Q39303131-F27DE7FF-CAC7-4334-9B07-5DC9DC52F0C0Q41704131-07447012-14F4-4CB8-8B57-D60D8C7D9CEFQ44792456-75008D42-396A-4E86-B455-8469E836B27AQ46328753-2B550790-E727-4118-A406-9F3E666DF83DQ51739297-E19E062F-BC21-443F-B409-600105087D3FQ52982588-47D83E89-5DBF-4760-9391-989B2730AD54Q57057499-621569DB-02B9-468C-AF98-61A3FF386C87Q57163637-811DE65F-18BA-474D-86A7-87B72C987B60Q57495835-9E88D486-C220-45A9-AD96-4A79626DEA23
P2860
Role of biomarkers in chemotherapy-induced cardiotoxicity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of biomarkers in chemotherapy-induced cardiotoxicity.
@ast
Role of biomarkers in chemotherapy-induced cardiotoxicity.
@en
type
label
Role of biomarkers in chemotherapy-induced cardiotoxicity.
@ast
Role of biomarkers in chemotherapy-induced cardiotoxicity.
@en
prefLabel
Role of biomarkers in chemotherapy-induced cardiotoxicity.
@ast
Role of biomarkers in chemotherapy-induced cardiotoxicity.
@en
P1476
Role of biomarkers in chemotherapy-induced cardiotoxicity.
@en
P2093
Daniela Cardinale
Maria Teresa Sandri
P304
P356
10.1016/J.PCAD.2010.04.002
P577
2010-09-01T00:00:00Z